A Chronic Myeloid Leukemia Case Diagnosed Following Acute Kidney İnjury Event

Öz

A chronic myeloid leukemia (CML) case following acute kidney injury (AKI) was reported here. 80 year old man, admitted to the clinic with oliguria and increasing in serum urea and creatinine levels. He was diagnosed as acute kidney injury (AKI) and treated supportively, but recovered partly; no renal replacement therapy was required. Four months later he was referred to the clinic again because of significant, persistent leukocytosis; after peripheral blood smear, bone marrow biopsy and BCR-ABL gene scanning examination, he was diagnosed as chronic myeloid leukemia.

Anahtar Kelimeler

• Acute Kidney Injury
• Chronic Myeloid Leukemia
• BCR-ABL Gene
• KDIGO Criteria

Akut Böbrek Hasarını Takiben Tanı Konan Kronik Miyeloid Lösemi Olgusu

Öz

Bu yazıda akut böbrek hasarını (AKI) takiben tanı alan bir kronik myeloid lösemi (KML) vakası bildirilmiştir. 80 yaşında erkek hasta, oligüri ve serum kreatinin düzeylerinde yükselme ile kliniğe başvurdu. Akut böbrek hasarı (AKI) teşhisi kondu ve destekleyici tedavi verildi,kısmen iyileşme sağlandı,renal replasman tedavisi gerekmedi. Dört ay sonra persistan lökositoz nedeniyle tekrar kliniğe başvurdu; periferik yayma,kemik iliği biyopsisi ve BCR-ABL gen tarama incelemesi sonrasında kronik myeloid lösemi tanısı kondu.

Anahtar Kelimeler

• Akut Böbrek Hasarı
• Kronik Myeloid Lösemi
• BCR-ABL Geni
• KDIGO Kriterleri

Kaynakça

1. 1.John A Kellum, Norbert Lameire , for the KDIGO AKI Guideline Work Group3 , Diagnosis, evaluation, and management of acute kidney injury: a KDIGO , Critical Care 2013, 17:204
2. 2. Rinaldo Bellomo , John A Kellum, Claudio Ronco , Acute kidney injury, Lancet 2012 May 21, PMID: 22617274,DOI: 10.1016/S0140-6736(11)61454-2
3. 3. Ashley Farrar , Acute Kidney Injury , 2018 Oct 11, Nurs Clin North Am ,DOI: 10.1016/j.cnur.2018.07.001
4. 4. CL Sawyers , Chronic Myeloid Leukemia , N Engl J Med 1999 Apr 29;340(17):1330-40. doi: 10.1056/NEJM199904293401706.
5. 5. Elias Jabbour , Hagop Kantarjian ,, Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring , American Journal of Hematology ,2018 Mar;93(3):442-459.doi: 10.1002/ajh.25011.
6. 6. Mughal TI, Goldman JM. Chronic myeloid leukaemia: STI 571 magnifiesthe therapeutic dilemma. Eur J Cancer. 2001;37:561–8
7. 7. Mitchell H. Rosner and Mark A. Perazella, Acute kidney injury in the patient with cancer , Kidney Res Clin Pract 2019 Sep 30. doi: 10.23876/j.krcp.19.042
8. 8.Maurizio Gallieni, Laura Cosmai, Camillo Porta , Acute Kidney Injury in Cancer Patients, Contrib Nephrology 2018;193:137-148, Epub 2018 Jan 23, doi: 10.1159/000484970.

9. 9.Mir MA, Delamore IW. Metabolic disorders in acute myeloid leukaemia. Br J Haematol 1978;40:79-92.
10. 10. Yukio Yuzawa, Waichi Sato , Tomohiro Masuda , Yuzuru Hamada , Miho Tatematsu , Yoshinari Yasuda , Takenori Ozaki , Isao Ito , Masashi Mizuno , Shoichi Maruyama , Yasuhiko Ito,Seiichi Matsuo, Acute Kidney Injury Presenting a Feature of Leukemic Infiltration during Therapy for Chronic Myelogenous Leukemia, Intern Med. 2010 Jun 15, DOI: 10.2169/internalmedicine.48.2747
11. 11.Kanno Y, Sakuyama M, Niitsu H, Ito T, Lee M, Ohtani H. Renal and electrolyte disturbances in chronic myelogenous leukemia. Rinsho Ketsueki 33: 1128-1135, 1992 (in Japanese).
12. 12. Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis 2014;21: 18-26.
13. 13. Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: a clinical review. World J Crit Care Med 2015;4: 130-138.
14. 14. Cairo MS, Bishop M. , Tumour lysis syndrome: new therapeutic strategies and classification , Br J Haematol 2004; 127:3-11.
15. 15. Pau Montesinos, Tumor lysis syndrome in patients with acute myeloid leukemia: Identification of risk factors and development of a predictive model, January 2008,Haematologica 93(1):67-74 DOI: 10.3324/haematol.11575
16. 16. Norbert Lameire, Raymond Vanholder , Wim Van Biesen and Dominique Benoit , Acute kidney injury in critically ill cancer patients: an update, Lameire et al. Critical Care (2016) 20:209 DOI 10.1186/s13054-016-1382-6